STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDRX
  4. [8-K] Veradigm Inc. Reports Material Event

Veradigm (NASDAQ: MDRX) sets Sept. investor talks with CEO and CFO

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Veradigm Inc. reported that its management team will participate in two investor conferences in September 2026, as a Regulation FD communication. At the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026, CEO Don Trigg and CFO Christian Greyenbuhl will hold one-on-one meetings and take part in a fireside chat at 4:10 PM CT, with a live webcast available on the company’s investor relations website. The same executives will also attend the Deutsche Bank 2026 Healthcare Summit in New York on September 16, 2026 for one-on-one meetings. Veradigm describes itself as a provider of clinical and revenue cycle solutions for independent practices, supporting over 20,000 provider practices with AI-focused data and technology.

Positive

  • None.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Conference date - Jefferies September 15, 2026 Date of Veradigm participation in the 2026 Jefferies Healthcare Services and Technology Conference
Fireside chat time 4:10 PM CT Scheduled time for Veradigm fireside chat at the Jefferies conference
Conference date - Deutsche Bank September 16, 2026 Date of Veradigm participation in the Deutsche Bank 2026 Healthcare Summit
Provider practices supported over 20,000 Number of provider practices Veradigm states its solutions and data help
Investor contact phone 312-506-1237 Phone number provided for Veradigm investor contact Steven Halper
Media contact phone 601-398-7000 Phone number provided for Veradigm media contact Katie Wilson
Regulation FD Disclosure regulatory
"Item 7.01 Regulation FD Disclosure"
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
fireside chat market
"will hold one-on-one meetings and participate in a fireside chat"
one-on-one meetings market
"will hold one-on-one meetings and participate in a fireside chat"
One-on-one meetings are private conversations between two people, typically a manager and an employee, where they discuss work progress, goals, and concerns. For investors, these meetings can reveal insights into a company's internal priorities, leadership focus, and overall health, helping them understand how well the organization is managing its resources and addressing challenges.
OTC Expert Market market
"Common Stock, par value $0.01 per share MDRX N/A (OTC Expert Market)"
An OTC expert market is an over-the-counter trading venue where securities that don’t meet the rules of main exchanges are bought and sold, and access is typically limited to professional or sophisticated investors. It matters to investors because these markets often have less public information, lower trading volume and higher price swings — like a specialized flea market where only experienced buyers trade rarer, riskier items, so potential reward and risk are both amplified.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

What did Veradigm (MDRX) announce in its latest 8-K filing?
Veradigm announced that management will participate in two September 2026 investor conferences, including Jefferies and Deutsche Bank events. The disclosure is made as a Regulation FD item without new financial results.

Which investor conferences will Veradigm (MDRX) attend in September 2026?
Veradigm will attend the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15 and the Deutsche Bank 2026 Healthcare Summit in New York on September 16, with management holding meetings and a fireside chat.

Will Veradigm (MDRX) provide a webcast of its conference appearance?
Yes. A live webcast of Veradigm’s fireside chat on September 15, 2026 at 4:10 PM CT during the Jefferies conference will be available on the company’s investor relations website for interested investors.

Who from Veradigm (MDRX) will represent the company at the September 2026 conferences?
Chief Executive Officer Don Trigg and Chief Financial Officer Christian Greyenbuhl will represent Veradigm at both the Jefferies Healthcare Services and Technology Conference and the Deutsche Bank 2026 Healthcare Summit.

How does Veradigm (MDRX) describe its business in this 8-K communication?
Veradigm describes itself as a provider of clinical and revenue cycle solutions for independent practices, using AI-forward data and technology to help more than 20,000 provider practices connect with health plans and biopharma.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
false0001124804NONE00011248042026-08-172026-08-17

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 17, 2026

 

 

VERADIGM INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-32085

36-4392754

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

222 Merchandise Mart

 

Chicago, Illinois

 

60654

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 800 334-8534

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

MDRX

 

N/A (OTC Expert Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Item 7.01 Regulation FD Disclosure.

On August 17, 2026, the Company issued a press release announcing that members of the Company's management will participate in two investor conferences in September 2026. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference. The information furnished pursuant to this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

 

 

 

Exhibit
No.

99.1

 

Press release issued by Veradigm Inc. on August 17, 2026

 

 

 

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

VERADIGM INC.

 

 

 

 

Date:

August 17, 2026

By:

/s/ Eric Jacobson

 

 

 

Eric Jacobson
Senior Vice President, Interim General Counsel
& Corporate Secretary
 

 

Exh. 99.1

img154799912_0.gif

Veradigm to Participate in Two Upcoming Investor Conferences

August 17, 2026

CHICAGO--(BUSINESS WIRE)--August 17, 2026 -- Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management will be participating in the following investor conferences in September.

2026 Jefferies Healthcare Services and Technology Conference (Nashville, September 15, 2026)

Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will hold one-on-one meetings and participate in a fireside chat on Tuesday, September 15th at 4:10PM CT. A live webcast of the fireside chat will be available at the Veradigm investor relations website.

Deutsche Bank 2026 Healthcare Summit (New York, September 16, 2026)

Don Trigg, Chief Executive Officer, and Christian Greyenbuhl, Chief Financial Officer, will participate in one-on-one meetings on Wednesday, September 16th. Investors should contact their Deutsche Bank representative for additional information.

About Veradigm®

Veradigm has a proven history of delivering clinical and revenue cycle solutions that help independent practices improve outcomes and financial performance. Our AI-forward data and technology also help over 20,000 provider practices connect with health plans and biopharma to eliminate inefficiencies, close care gaps, and create a more affordable health system.

© 2026 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or Company names are the property of their respective holders, all rights reserved.

 

For more information contact:

Investors:
Steven Halper

312-506-1237

steven.halper@veradigm.com

Media:

Katie Wilson 601-398-7000

katie.wilson@veradigm.com

Source: Veradigm

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

2 documents

Press Releases

Other Documents